Spironolactone (INN)
Spironolactone (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Spironolactone
Spironolactone is a steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7. It has a role as a diuretic, an antihypertensive agent, a xenobiotic, an aldosterone antagonist and an environmental contaminant. It is a steroid lactone, an oxaspiro compound, a 3-oxo-Delta(4) steroid and a thioester. — ChEBI
- IUPAC name
- S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate
- Molecular formula
- C24H32O4S
- Molecular weight
- 416.6 g/mol
- Exact mass
- 416.20213067 Da
- XLogP3
- 2.9
- Topological polar surface area
- 85.7 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 5
- Covalent units
- 1
- Defined stereocentres
- 7
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:9241
- ChEMBL:CHEMBL1393
- EPA DTXSID:DTXSID6034186
- PubMed:31065620
- PubMed:28024992
- PubMed:23116347
- PubMed:23105506
- PubMed:23077889
- PubMed:23077888
- PubMed:23077601
- PubMed:23074496
- PubMed:23074464
- PubMed:23060371
- PubMed:23035601
- PubMed:23031616
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Spironolactone (INN)
Regulatory information
Identified ingredients
Key data
Inventory links for Spironolactone (INN)
Related records for Spironolactone (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid (Tiratricol (INN)) and its salts
(2-Acetoxyethyl)trimethylammonium hydroxide (Acetylcholine) and its salts
Aminocaproic acid (INN) and its salts
Cinchophen (INN), its salts, derivatives and salts of these derivatives
Aconitum napellus L. (leaves, roots and galenical preparations)
Aconitine (principal alkaloid of Aconitum napellus L.) and its salts
Adonis vernalis L. and its preparations
What Annex II means for Spironolactone (INN)
Spironolactone (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Spironolactone (INN)
This page summarizes one Annex II record for Spironolactone (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Spironolactone (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Spironolactone (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Spironolactone (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II